Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.77 USD | +2.52% |
|
+32.21% | +50.31% |
02/07 | Avid Bioservices Fiscal Q4 Loss Widens, Revenue Increases; Fiscal 2025 Revenue Outlook Set | MT |
02/07 | Transcript : Avid Bioservices, Inc., Q4 2024 Earnings Call, Jul 02, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+50.31% | 61Cr | |
+7.90% | 10TCr | |
+11.97% | 4.23TCr | |
-11.76% | 3.28TCr | |
+79.34% | 2.95TCr | |
-12.20% | 1.63TCr | |
+4.00% | 1.44TCr | |
-1.90% | 1.22TCr | |
+178.17% | 1.05TCr | |
+1.80% | 896.68Cr |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- Avid Bioservices Fiscal Q2 Loss Widens, Revenue Falls; Cuts Fiscal 2024 Sales Outlook; Shares Plunge Premarket